Objective: Patients with coronary artery disease complicated by moderate ischemic mitral regurgitation have demonstrably poorer outcome than do patients with coronary artery disease but without mitral regurgitation. The optimal treatment of this condition has become increasingly controversial, and a randomized trial evaluating current practices is warranted.
Methods: We describe the design and initial execution of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial.
Results: This is an ongoing prospective, multicenter, randomized, controlled clinical trial designed to test the safety and efficacy of mitral repair in addition to coronary artery bypass grafting in the treatment of moderate ischemic mitral regurgitation.
Conclusions: The results of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial will provide long-awaited information on controversial therapies for this morbid disease process.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166424 | PMC |
| http://dx.doi.org/10.1016/j.jtcvs.2011.05.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study.
Diabetes Obes Metab
December 2024
Department of Medicine, University of Verona, Verona, Italy.
Aims: Whether the plasma-based ceramide-based risk score CERT1 improves risk prediction for cardiovascular disease (CVD) is uncertain.
Materials And Methods: Baseline and follow-up data were combined from two cohorts, 334 patients with established/suspected CVD and 196 patients with type 2 diabetes followed for a median of 74 months (interquartile range 54-79 months). For the calculation of CERT1 risk score, we measured four specific plasma ceramides [Cer(d18:1/16:0), Cer(d18:1/18:0) and Cer(d18:1/24:1)] and their ratios to Cer(d18:1/24:0).
The association of reduced ejection fraction with the outcomes of endovascular abdominal aortic aneurysm repair.
J Vasc Surg
December 2024
Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale School of Medicine, New Haven, Connecticut.
Objectives: It is estimated that 20% of patients undergoing elective abdominal aortic aneurysm (AAA) repair suffer from cardiomyopathy. This study examines the impact of reduced ejection fraction (EF) on the outcomes of endovascular aneurysm repair (EVAR) and compares the different types of cardiomyopathies causing reduction of EF. Our hypothesis is that reduction in EF is associated with higher mortality after EVAR.
View Article and Find Full Text PDFShortened NIHSS for Rapid Stroke Assessment in Emergency Care Settings.
Neurologist
December 2024
Emergency Medicine Department, Emergency Medicine Research Team, Tabriz University of Medical Sciences, Tabriz, Iran.
Objectives: The National Institutes of Health Stroke Scale (NIHSS) is widely used to assess ischemic stroke severity, but its full 11-item version can be time-consuming. This study evaluates the NIHSS-8, a shortened version, for its efficacy compared with NIHSS-11 in an emergency department setting.
Methods: A cohort study was conducted from May 2018 to May 2019 at Imam Reza Hospital, Tabriz, Iran.
Screening Prediction Models Using Artificial Intelligence for Moderate-to-Severe Obstructive Sleep Apnea in Patients With Acute Ischemic Stroke.
J Stroke Cerebrovasc Dis
December 2024
Department of Healthcare Administration and Medical Informatics, Kaohsiung Medical University, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; College of Professional Studies, National Pingtung University of Science and Technology, Pingtung, Taiwan. Electronic address:
Background: Obstructive sleep apnea (OSA) is common after stroke. Still, routine screening of OSA with polysomnography (PSG) is often unfeasible in clinical practice, primarily because of how limited resources are and the physical condition of patients. In this study, we used several artificial intelligence techniques to predict moderate-to-severe OSA and identify its features in patients with acute ischemic stroke.
View Article and Find Full Text PDFThreshold hemoglobin level for delayed cerebral ischemia: A single-center retrospective analysis.
Heliyon
December 2024
Departmant of Neurosurgery, University of Health Sciences Ankara Etlik City Hospital, Ankara, Turkey.
Background: Delayed cerebral ischemia (DCI) occurs in approximately 20%-30 % of patients with subarachnoid hemorrhage (SAH). This is the most common complication of SAH and has a high mortality rate. In the present study, we investigated the relationship between hemoglobin (Hb) values and DCI and aimed to determine a cutoff Hb value to be used as a predictor of DCI.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!